|  | |
| Clinical data | |
|---|---|
| Routes of administration | IV | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H10N4O | 
| Molar mass | 250.261 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Olprinone (INN) is a cardiotonic agent.[1] It has been marketed in Japan since 1996.[2]
References
- ↑ Uemura Y, Tanaka S, Ida S, Yuzuriha T (December 1993). "Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs". J. Pharm. Pharmacol. 45 (12): 1077–81. doi:10.1111/j.2042-7158.1993.tb07184.x. PMID 7908977.
- ↑ (in English)"Coretec Injection 5 mg" (PDF). Eisai Co. April 2005. Retrieved 2008-06-26.
External links
 Media related to Olprinone at Wikimedia Commons Media related to Olprinone at Wikimedia Commons
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.